Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales Rep Overtime Suit Score Card: Alpharma Wins Latest Ruling

Executive Summary

While Novartis and Schering-Plough sales reps recently won favorable rulings in their suits for overtime pay, reps at King's Alpharma unit struck out

You may also be interested in...



Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry

The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.

Sales Rep Overtime Might Get Supreme Court Review; "Staggering Retroactive Liability" Is Worry

The court will consider certiorari petitions from Novartis and Schering at its Feb. 18 conference. An amicus brief from PhRMA paints a dire picture.

Pharma Industry Likely To Take Wait-And-See Approach To GSK U.S. Sales Incentive Changes

Like the canaries that miners used to take deep into the coal mines with them to ensure the air was of breathing quality, GlaxoSmithKline sales representatives will play a pioneering role starting next year when new compensation practices based not on sales totals but instead on customer service are implemented

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel